Successful Integration of Hepatitis C Virus Point-of-Care Tests into the Denver Metro Health Clinic

by Jewett, A., Al-Tayyib, A. A., Ginnett, L., Smith, B. D.
Published 2013

Clinical, pharmacokinetic and pharmacodynamic data for the MEK1/2 inhibitor pimasertib in patients with advanced hematologic malignancies

by Ravandi, F, Pigneux, A, DeAngelo, D J, Raffoux, E, Delaunay, J, Thomas, X, Kadia, T, Kantarjian, H, Scheuenpflug, J, Zhao, C, Guo, W, Smith, B D
Published 2015

Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy

by Qin, L, Smith, B D, Tsai, H-L, Yaghi, N K, Neela, P H, Moake, M, Fu, J, Kasamon, YL, Prince, G T, Goswami, M, Rosner, G L, Levitsky, H I, Hourigan, C S
Published 2013

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues

by Goswami, M, Hensel, N, Smith, B D, Prince, G T, Qin, L, Levitsky, H I, Strickland, S A, Jagasia, M, Savani, B N, Fraser, J W, Sadrzadeh, H, Rajkhowa, T, Ito, S, Jain, N A, Battiwalla, M, Fathi, A T, Levis, M J, Barrett, A J, Hourigan, C S
Published 2014